Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Cephalon (UK) Limited
Teva UK Limited, Field House, Station Approach, Harlow, Essex, CM20 2FB
Telephone: +44 (0) 207 5407117
Fax: +44 (0) 207 4507349
WWW: http://www.tevauk.com
Medical Information Direct Line: +44 (0) 207 5407117
Medical Information e-mail: medinfo@tevauk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 25/10/2011
PIL Dilzem XL 120, 180 and 240mg hard-capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 03/05/2011 and displayed until 25/10/2011
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to Marketing Authorisation Number
Updated on 15/12/2010 and displayed until 03/05/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to manufacturer contact details
Updated on 16/09/2010 and displayed until 15/12/2010
Reasons for adding or updating:
  • Change to Further Information section
Updated on 27/08/2010 and displayed until 16/09/2010
Reasons for adding or updating:
  • Change to storage instructions
Updated on 05/11/2009 and displayed until 27/08/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 09/01/2009 and displayed until 05/11/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 28/10/2008 and displayed until 09/01/2009
Reasons for adding or updating:
  • Change to name of manufacturer
  • Change to MA holder contact details
Updated on 14/05/2008 and displayed until 28/10/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 11/03/2008 and displayed until 14/05/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to drug interactions
  • Change to side-effects
  • Change of inactive ingredient
Updated on 01/08/2006 and displayed until 11/03/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 02/08/2001 and displayed until 01/08/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 07/08/2000 and displayed until 02/08/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  diltiazem hydrochloride